Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Study of Proton Therapy in Adjuvant Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating proton therapy as adjuvant treatment after surgical resection for pancreatic adenocarcinoma has complete…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas [EARLY_Phase 1]
An early-phase pilot study at Johns Hopkins evaluated a combination of CY (cyclophosphamide), pembrolizumab, GVAX pancreatic cancer vaccine,…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II study of OBI-3424 in advanced solid tumors, including pancreatic adenocarcinoma, has been terminated.
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating neoadjuvant chemotherapy before surgery for pancreatic adenocarcinom…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: Phase 2 Study of Irinotecan Liposome Injection, Oxaliplatin, 5-fluorouracil/Levoleucovorin in Japanese Participants Not Previously Treated for Metastatic Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 study evaluating a triplet regimen of liposomal irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin in Japanese patients with pre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2024-10-04Clinical Trial Update: Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy [NA]
ClinicalTrials.gov trial NCT04571294 evaluates para-aortic lymph node removal during upfront pancreaticoduodenectomy for pancreatic cancer, …
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma [Phase 1, Phase 2]
The document reports completion of a Phase 1/2 trial evaluating STR plus an anti-PD-1 therapy in patients with locally advanced unresectable…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating liposomal irinotecan in combination with 5-FU and oxaliplatin as preoperative therapy for pancreatic adenocarcino…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Prospective Evaluation of MRI Biomarkers in Pancreatic Ductal Adenocarcinoma [NA]
This document provides a status update on a prospective study evaluating MRI biomarkers in pancreatic adenocarcinoma, with the trial status …
-
CLINICAL_TRIALS other · 2024-09-19Clinical Trial Update: BATs Treatment for Pancreatic Cancer, Phase Ib/II [Phase 1, Phase 2]
A clinical trial update indicates that BATs treatment is being investigated in Phase Ib/II for locally advanced and metastatic pancreatic ad…
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients [Phase 2]
Phase 2 study evaluating the safety and efficacy of combining BL-8040 (motixafortide) with pembrolizumab in metastatic pancreatic adenocarci…
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) [Phase 2]
A Phase 2 trial (CAPE-X) evaluating CAPEcitabine as adjuvant therapy for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]
Phase 2 trial evaluating GVAX pancreatic tumor cell vaccine with cyclophosphamide, SBRT, and the FOLFIRINOX regimen in patients with resecte…
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma
A completed clinical trial update examining whether albumin levels, HALP score, and LCR value can predict survival and recurrence in pancrea…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer [Phase 2]
Phase 2 trial of NIS793 in combination with FOLFIRINOX for pancreatic cancer was terminated, with results posted on 2024-07-16.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: The Application of DNA Nanomachines for Detecting microRNA in Blood for the Diagnosis of Pancreatic Cancer. Diagnosis of Pancreatic Cancer
A clinical trial exploring DNA nanomachines to detect microRNA in blood as a diagnostic tool for pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial of NanoPac in locally advanced pancreatic adenocarcinoma has completed, with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 [Phase 2]
Phase 2 FLUOPANC trial evaluating fluorescence-guided surgery for pancreatic adenocarcinoma and cholangiocarcinoma using the fluorescent age…
-
CLINICAL_TRIALS trial_result · 2024-06-20Clinical Trial Update: Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer [Phase 2]
Phase 2 trial evaluating epacadostat with pembrolizumab and CRS-207, with or without cyclophosphamide and GVAX Pancreas vaccine, in metastat…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors [Phase 1]
Clinical trial update reporting completion of a Phase 1 study evaluating AB011 in CLDN18.2-positive advanced solid tumors including gastric …
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Pancreatic Cancer Early Detection Program
A clinical trial update for White Plains Hospital describes an active, not currently recruiting program focused on early detection of pancre…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for a combination of liposomal irinotecan, fluorouracil, leucovorin, and rucaparib in pati…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
A post-marketing clinical registry update in Italy for OncoSil in locally advanced pancreatic adenocarcinoma, with recruitment not yet start…